Skip to main content

Pyrosequencing Completes Biotage Acquisition

NEW YORK, Oct. 29 (GenomeWeb News) - Pyrosequencing said today it has completed the acquisition of Biotage, which the parties announced Oct. 14.

 

In the acquisition, Pyrosequencing, of Uppsala, Sweden, said it made a cash payment of 235 million SEK ($30.5 million  ) and took over a mortgage of 36 million SEK for Biotage's Virginia premises.

 

The acquisition is the second this year for Pyrosequencing. The company acquired Personal Chemistry in September.

 

The company said it will now have about 275 employees, and also said it will likely change its name to Biotage.

 

 

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.